Skin Neurofibroma — Trials

Skin Neurofibroma — Trials · CancerIndex

Clinical trials

Registered studies

9 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06159166	Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).(Mirda)	recruiting	Phase 1 / Phase 2	24	Johns Hopkins UniversityOTHER	1	Apr 13, 2026	clinicaltrials
NCT05005845	NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)	completed	Phase 2	199	NFlection Therapeutics, Inc.INDUSTRY	1	Feb 17, 2026	clinicaltrials
NCT02839720	Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma	completed	Phase 2	11	National Cancer Institute (NCI)NIH	1	Dec 6, 2023	clinicaltrials
NCT04435665	NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)	completed	Phase 2	48	NFlection Therapeutics, Inc.

Data updated 22 days agoSource updated Apr 13, 2026source: clinicaltrials